(1)
Prediction of Long-Term Scalp Hair Regrowth at 24 Months in Patients With Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program. J of Skin 2025, 9 (2), s561. https://doi.org/10.25251/skin.10.supp.561.